Multiple Sclerosis

Multiple Sclerosis News

  • Crunch Week Looms for Sanofi, Roche and GSK at U.S. Drugs Agency Three of Europe's top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi and Roche likely to win approvals for two new products, while GlaxoSmithKline braces for a potential generic rival.
  • AAN Fatigue, Limb Problems Predict Worsening MS New research suggests clinicians should be aware of patient-reported functional issues to help identify patients most likely to progress.

Multiple Sclerosis Perspective